These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8678231)

  • 1. Rocuronium in the myasthenic patient.
    Baraka A; Haroun-Bizri S; Kawas N; Hajjar AM; Kawkabani N
    Anaesthesia; 1995 Nov; 50(11):1007. PubMed ID: 8678231
    [No Abstract]   [Full Text] [Related]  

  • 2. Rocuronium in two myasthenic patients undergoing thymectomy.
    Sanfilippo M; Fierro G; Cavalletti MV; Biancari F; Vilardi V
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1365-6. PubMed ID: 9422307
    [No Abstract]   [Full Text] [Related]  

  • 3. Fade of train-of-four ratio despite administration of more than 12 mg kg(-1) sugammadex in a myasthenia gravis patient receiving rocuronium.
    Kiss G; Lacour A; d'Hollander A
    Br J Anaesth; 2013 May; 110(5):854-5. PubMed ID: 23599531
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
    De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
    Anesthesiology; 2003 Jan; 98(1):133-42. PubMed ID: 12502989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible abnormal response to rocuronium in a patient taking multiple fitness supplements.
    Brett CN; Roberts SJ
    Anaesth Intensive Care; 2016 Sep; 44(5):640-1. PubMed ID: 27608352
    [No Abstract]   [Full Text] [Related]  

  • 7. Rocuronium and rapid sequence induction.
    Playfair PA; Uncles DR
    Anaesthesia; 1995 Jul; 50(7):663. PubMed ID: 7653779
    [No Abstract]   [Full Text] [Related]  

  • 8. The interaction between mivacurium and rocuronium during onset and recovery.
    Mirakhur RK
    Anaesthesia; 1997 Mar; 52(3):280. PubMed ID: 9124674
    [No Abstract]   [Full Text] [Related]  

  • 9. The interaction between mivacurium and rocuronium during onset and recovery.
    England AJ; Feldman SA
    Anaesthesia; 1997 Mar; 52(3):279-80. PubMed ID: 9124673
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
    De Haes A; Proost JH; Kuks JB; van den Tol DC; Wierda JM
    Anesth Analg; 2002 Sep; 95(3):588-96, table of contents. PubMed ID: 12198043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy].
    Komasawa N; Noma H; Sugi T; Sukenaga N; Kakiuchi H
    Masui; 2011 Apr; 60(4):476-9. PubMed ID: 21520600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].
    Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K
    Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between sevoflurane and propofol neuromuscular effects in a patient with myasthenia gravis: effective doses of vecuronium.
    Itoh H; Shibata K
    Anesthesiology; 2001 Sep; 95(3):803-5. PubMed ID: 11575561
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of rocuronium (ORG 9426) in patients with chronic renal failure.
    Khuenl-Brady KS; Pomaroli A; Pühringer F; Mitterschiffthaler G; Koller J
    Anaesthesia; 1993 Oct; 48(10):873-5. PubMed ID: 8238829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of magnesium sulphate before rocuronium: effects on speed of onset and duration of neuromuscular block.
    Kussman B; Shorten G; Uppington J; Comunale ME
    Br J Anaesth; 1997 Jul; 79(1):122-4. PubMed ID: 9301400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency and recovery characteristics of rocuronium mixed with sodium bicarbonate.
    Lee HJ; Kim KS; Yeon JT; Suh JK; Sung IH; Shin IC
    Anaesthesia; 2010 Sep; 65(9):899-903. PubMed ID: 20608923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin.
    Spacek A; Nickl S; Neiger FX; Nigrovic V; Ullrich OW; Weindmayr-Goettel M; Schwall B; Taeger K; Kress HG
    Anesthesiology; 1999 Jun; 90(6):1551-5. PubMed ID: 10360851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study.
    Fujimoto M; Terasaki S; Nishi M; Yamamoto T
    Eur J Anaesthesiol; 2015 Oct; 32(10):672-80. PubMed ID: 26086278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and onset time of neuromuscular relaxants.
    Feldman SA
    Anaesthesia; 1997 Apr; 52(4):387-8. PubMed ID: 9135202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.